Mi Kyung Kim, et al.
Science Translational Medicine. 2013 May 15;5(185):185ra63 – Download the article
Publication
Oncolytic and immunotherapeutic vaccinia induces antibody-mediated complement-dependent cancer cell lysis in humans
Par alcyon|2019-07-03T14:11:50+02:00mai 15th, 2013|Pexa-Vec, Publication|Commentaires fermés sur Oncolytic and immunotherapeutic vaccinia induces antibody-mediated complement-dependent cancer cell lysis in humans
À propos de l'auteur : alcyon
Articles similaires
- TG4001 (Tipapkinogene sovacivec) and avelumab for recurrent/metastatic (R/M) Human Papilloma Virus (HPV)-16+ cancers: clinical efficacy and immunogenicity
TG4001 (Tipapkinogene sovacivec) and avelumab for recurrent/metastatic (R/M) Human Papilloma Virus (HPV)-16+ cancers: clinical efficacy and immunogenicity